Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Dana Alonzo. (2022) Pros and cons of mental health treatment: reports from depressed clients with suicidal ideation. Journal of Mental Health 31:3, pages 332-339.
Read now
Read now
Valentin Yurievich Skryabin, Maria Vinnikova, Anna Nenastieva & Vladislav Alekseyuk. (2018) Hallucinogen persisting perception disorder: A literature review and three case reports. Journal of Addictive Diseases 37:3-4, pages 268-278.
Read now
Read now
Bernardo Dell’Osso, Umberto Albert, Anna Rita Atti, Claudia Carmassi, Giuseppe Carrà, Fiammetta Cosci, Valeria Del Vecchio, Marco Di Nicola, Silvia Ferrari, Arianna Goracci, Felice Iasevoli, Mario Luciano, Giovanni Martinotti, Maria Giulia Nanni, Alessandra Nivoli, Federica Pinna, Nicola Poloni, Maurizio Pompili, Gaia Sampogna, Ilaria Tarricone, Sarah Tosato, Umberto Volpe & Andrea Fiorillo. (2015) Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice. Neuropsychiatric Disease and Treatment 11, pages 1885-1909.
Read now
Read now
Paweł Kawalec, Agnieszka Cierniak, Andrzej Pilc & Gabriel Nowak. (2015) Pregabalin for the treatment of social anxiety disorder. Expert Opinion on Investigational Drugs 24:4, pages 585-594.
Read now
Read now
Articles from other publishers (25)
Anish Poorna T, Lokesh JR, Joshna EK, Bobby John, Neethu S & Shankar S. (2022) Extracranial schwannoma of the maxillary nerve misdiagnosed as trigeminal neuralgia in an elderly patient with schizophrenia – A diagnostic dilemma. Special Care in Dentistry 43:2, pages 276-280.
Crossref
Crossref
Amina A. Alkhalaf, Raneem A. Bukhari, Elham A. Alshehri, Samah O. Alshehri & Aisha F. Badr. (2021) Abuse liability of gabapentin in the Saudi population after the pregabalin restriction: A cross-sectional study. Journal of Taibah University Medical Sciences 16:5, pages 700-705.
Crossref
Crossref
Mohamed Abdelghani, Amira A. Fouad, Aya Mamdouh & Yasser M. Raya. (2020) Association Between Cognitive Impairment and Substance Use Disorder Attributed to Pregabalin in Egypt: A Case-Control Study. Addictive Disorders & Their Treatment 19:4, pages 201-208.
Crossref
Crossref
Arash Mowla & Mehrnoosh Ghaedsharaf. (2019) Pregabalin augmentation for resistant obsessive–compulsive disorder: a double-blind placebo-controlled clinical trial. CNS Spectrums 25:4, pages 552-556.
Crossref
Crossref
Kirk E. Evoy, Jordan R. Covvey, Alyssa M. Peckham, Leslie Ochs & Kyle E. Hultgren. (2019) Reports of gabapentin and pregabalin abuse, misuse, dependence, or overdose: An analysis of the Food And Drug Administration Adverse Events Reporting System (FAERS). Research in Social and Administrative Pharmacy 15:8, pages 953-958.
Crossref
Crossref
Amneh Al-Husseini, Marie Claire Van Hout & Mayyada Wazaify. (2018) Pregabalin Misuse and Abuse: A Scoping Review of Extant Literature. Journal of Drug Issues 48:3, pages 356-376.
Crossref
Crossref
Federica Ianni, Kyriaki Aroni, Alessio Gili, Roccaldo Sardella, Mauro Bacci, Massimo Lancia, Benedetto Natalini & Cristiana Gambelunghe. (2018) GC‐MS/MS detects potential pregabalin abuse in susceptible subjects’ hair. Drug Testing and Analysis 10:6, pages 968-976.
Crossref
Crossref
Lucia Ioime, Riccardo Guglielmo, Giuseppe Fertonani Affini, Marianna Quatrale, Giovanni Martinotti, Antonino Callea, Evelina Savi & Luigi Janiri. (2018) Neuropsychological Performance in Alcohol Dependent Patients: A One-Year Longitudinal Study. Psychiatry Investigation 15:5, pages 505-513.
Crossref
Crossref
Giovanni Martinotti, Rita Santacroce, Mauro Pettorruso, Chiara Montemitro, Maria Spano, Marco Lorusso, Massimo di Giannantonio & Arturo Lerner. (2018) Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives. Brain Sciences 8:3, pages 47.
Crossref
Crossref
Kirk E. Evoy, Megan D. Morrison & Stephen R. Saklad. (2017) Abuse and Misuse of Pregabalin and Gabapentin. Drugs 77:4, pages 403-426.
Crossref
Crossref
Hiba Alblooshi, Gary K. Hulse, Ahmed El Kashef, Hanan Al Hashmi, Mansour Shawky, Hamad Al Ghaferi, Habiba Al Safar & Guan K. Tay. (2016) The pattern of substance use disorder in the United Arab Emirates in 2015: results of a National Rehabilitation Centre cohort study. Substance Abuse Treatment, Prevention, and Policy 11:1.
Crossref
Crossref
Rainer Freynhagen, Miroslav Backonja, Stephan Schug, Gavin Lyndon, Bruce Parsons, Stephen Watt & Regina Behar. (2016) Pregabalin for the Treatment of Drug and Alcohol Withdrawal Symptoms: A Comprehensive Review. CNS Drugs 30:12, pages 1191-1200.
Crossref
Crossref
Idaira Oliva & Matthew J. Wanat. (2016) Ventral Tegmental Area Afferents and Drug-Dependent Behaviors. Frontiers in Psychiatry 7.
Crossref
Crossref
Giovanni Martinotti, Georgios Papazisis, Rita Santacroce, Dimitrios Kouvelas, Eduardo Cinosi, Matteo Lupi & Massimo di Giannantonio. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse
945
951
.
Giulia Francesconi, Laura Orsolini, Duccio Papanti, John M. Corkery & Fabrizio Schifano. (2015) Venlafaxine as the ‘baby ecstasy’? Literature overview and analysis of web-based misusers′ experiences. Human Psychopharmacology: Clinical and Experimental 30:4, pages 255-261.
Crossref
Crossref
N. N. Ivanets, M. A. Kinkulkina, T. I. Avdeeva & Yu. G. Tikhonova. (2015) Remote consequences of the long-term uncontrollable consumption of anxiolytics and hypnotics in elderly: a problem of drug dependence. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 115:7, pages 47.
Crossref
Crossref
Giovanni Martinotti, Marco Di Nicola, Ofelia De Vita, Daniele Stavros Hatzigiakoumis, Riccardo Guglielmo, Barbara Santucci, Fererica Aliotta, Roberto Romanelli, Valeria Verrastro, Filippo Petruccelli, Massimo Di Giannantonio & Luigi Janiri. (2014) Low-Dose Topiramate in Alcohol Dependence. Journal of Clinical Psychopharmacology 34:6, pages 709-715.
Crossref
Crossref
Mehtap Bozkurt, Cuneyt Gocmez, Haluk Soylemez, Mansur Daggulli, Serda Em, Mehmet Yildiz, Murat Atar, Yasar Bozkurt & Isa Ozbey. (2014) Association Between Neuropathic Pain, Pregabalin Treatment, and Erectile Dysfunction. The Journal of Sexual Medicine 11:7, pages 1816-1822.
Crossref
Crossref
Vikas Kapil, Jody L. Green, Marie-Claire Le Lait, David M. Wood & Paul I. Dargan. (2014) Misuse of the γ-aminobutyric acid analogues baclofen, gabapentin and pregabalin in the UK. British Journal of Clinical Pharmacology 78:1, pages 190-191.
Crossref
Crossref
Fabio Caputo, Teo Vignoli, Alice Grignaschi, Mauro Cibin, Giovanni Addolorato & Mauro Bernardi. (2014) Pharmacological management of alcohol dependence: From mono-therapy to pharmacogenetics and beyond. European Neuropsychopharmacology 24:2, pages 181-191.
Crossref
Crossref
Mauro Pettorruso, Luisa De Risio, Giovanni Martinotti, Marco Di Nicola, Filippo Ruggeri, Gianluigi Conte, Massimo Di Giannantonio & Luigi Janiri. (2014) Targeting the Glutamatergic System to Treat Pathological Gambling: Current Evidence and Future Perspectives. BioMed Research International 2014, pages 1-11.
Crossref
Crossref
Emilio Blanco Tarrio, Rafael Gálvez Mateos, Enric Zamorano Bayarri, Vanessa López Gómez & Maria Pérez Páramo. (2013) Effectiveness of Pregabalin as Monotherapy or Combination Therapy for Neuropathic Pain in Patients Unresponsive to Previous Treatments in a Spanish Primary Care Setting. Clinical Drug Investigation 33:9, pages 633-645.
Crossref
Crossref
Johan Franck & Nitya Jayaram-Lindström. (2013) Pharmacotherapy for alcohol dependence: status of current treatments. Current Opinion in Neurobiology 23:4, pages 692-699.
Crossref
Crossref
Maximilian Gahr, Roland. W. Freudenmann, Christoph Hiemke, Makus A. Kölle & Carlos Schönfeldt-Lecuona. (2013) Pregabalin abuse and dependence in Germany: results from a database query. European Journal of Clinical Pharmacology 69:6, pages 1335-1342.
Crossref
Crossref
Riccardo Guglielmo, Giovanni Martinotti, Massimo Clerici & Luigi Janiri. (2012) Pregabalin for Alcohol Dependence: A Critical Review of the Literature. Advances in Therapy 29:11, pages 947-957.
Crossref
Crossref